Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 503

1.

Benign prostatic hyperplasia endoscopic surgical procedures in kidney transplant recipients: a comparison between HoLEP, GreenLight photoselective vaporization of the prostate and TURP.

Prudhomme T, Marquette T, Péré M, Patard PM, Michiels C, Sallusto F, Rigaud J, Glémain P, Kamar N, Blancho G, Soulie M, Rischmann P, Karam G, Gamé X, Robert G, Branchereau J.

J Endourol. 2019 Oct 5. doi: 10.1089/end.2019.0430. [Epub ahead of print]

PMID:
31588793
2.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
3.

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.

Gordon CE, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Earley A, Di M, Cheung M, Jadoul M, Martin P.

Ann Intern Med. 2019 Sep 24. doi: 10.7326/M19-1539. [Epub ahead of print]

PMID:
31546256
4.

Hepatitis E virus infections in Europe.

Izopet J, Tremeaux P, Marion O, Migueres M, Capelli N, Chapuy-Regaud S, Mansuy JM, Abravanel F, Kamar N, Lhomme S.

J Clin Virol. 2019 Sep 8;120:20-26. doi: 10.1016/j.jcv.2019.09.004. [Epub ahead of print]

PMID:
31536936
5.

Long-term, prolonged-release tacrolimus-based immunosuppression in de novo kidney transplant recipients: 5-year prospective follow-up of the ADHERE study patients.

Rummo O, Carmellini M, Kamar N, Durrbach A, Mousson C, Caputo F, Mathe Z, Christiaans MHL, Rj Kuypers D, Klempnauer J, Anaokar S, Hurst M, Kazeem G, Undre N, Lehner F.

Transpl Int. 2019 Sep 19. doi: 10.1111/tri.13527. [Epub ahead of print]

PMID:
31536654
6.

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.

Loupy A, Aubert O, Orandi BJ, Naesens M, Bouatou Y, Raynaud M, Divard G, Jackson AM, Viglietti D, Giral M, Kamar N, Thaunat O, Morelon E, Delahousse M, Kuypers D, Hertig A, Rondeau E, Bailly E, Eskandary F, Böhmig G, Gupta G, Glotz D, Legendre C, Montgomery RA, Stegall MD, Empana JP, Jouven X, Segev DL, Lefaucheur C.

BMJ. 2019 Sep 17;366:l4923. doi: 10.1136/bmj.l4923.

7.

Early necrotic skin lesions after an ABO-incompatible kidney transplantation: the threat of Cunninghamella Spp.

Belliere J, Rolland M, Tournier E, Cassaing S, Iriart X, Paul C, Kamar N.

Transpl Infect Dis. 2019 Sep 16:e13173. doi: 10.1111/tid.13173. [Epub ahead of print]

PMID:
31529558
8.

Adherence profiles in kidney transplant patients: Causes and consequences.

Villeneuve C, Rousseau A, Rerolle JP, Couzi L, Kamar N, Essig M, Etienne I, Westeel PF, Büchler M, Esposito L, Thierry A, Marquet P, Monchaud C.

Patient Educ Couns. 2019 Aug 7. pii: S0738-3991(19)30318-0. doi: 10.1016/j.pec.2019.08.002. [Epub ahead of print]

PMID:
31447197
9.

Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case-control study.

Wang Y, Liu H, Liu S, Yang C, Jiang Y, Wang S, Liu A, Peppelenbosch MP, Kamar N, Pan Q, Zhao J.

Liver Int. 2019 Aug 22. doi: 10.1111/liv.14221. [Epub ahead of print]

PMID:
31436371
10.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.

Barrail-Tran A, Goldwirt L, Gelé T, Laforest C, Lavenu A, Danjou H, Radenne S, Leroy V, Houssel-Debry P, Duvoux C, Kamar N, De Ledinghen V, Canva V, Conti F, Durand F, D'Alteroche L, Botta-Fridlund D, Moreno C, Cagnot C, Samuel D, Fougerou-Leurent C, Pageaux GP, Duclos-Vallée JC, Taburet AM, Coilly A.

Eur J Clin Pharmacol. 2019 Aug 5. doi: 10.1007/s00228-019-02725-x. [Epub ahead of print]

PMID:
31384986
11.

Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.

Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H.

Transplant Rev (Orlando). 2019 Oct;33(4):191-199. doi: 10.1016/j.trre.2019.07.001. Epub 2019 Jul 23. Review.

PMID:
31377099
12.

Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.

Del Bello A, Divard G, Belliere J, Congy-Jolivet N, Lanfranco L, Ricard R, Delas A, Colombat M, Esposito L, Hebral AL, Cointault O, Lefaucheur C, Loupy A, Kamar N.

Clin Transplant. 2019 Aug 1:e13681. doi: 10.1111/ctr.13681. [Epub ahead of print]

PMID:
31369170
13.

Transfusion-Transmitted Hepatitis E Virus Infection in France.

Gallian P, Pouchol E, Djoudi R, Lhomme S, Mouna L, Gross S, Bierling P, Assal A, Kamar N, Mallet V, Roque-Afonso AM, Izopet J, Tiberghien P.

Transfus Med Rev. 2019 Jul;33(3):146-153. doi: 10.1016/j.tmrv.2019.06.001. Epub 2019 Jun 20. Review.

PMID:
31327668
14.

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.

Lhomme S, DebRoy S, Kamar N, Abravanel F, Metsu D, Marion O, Dimeglio C, Cotler SJ, Izopet J, Dahari H.

Viruses. 2019 Jul 9;11(7). pii: E630. doi: 10.3390/v11070630.

15.

Outcomes of kidney transplant recipients admitted to the intensive care unit: a retrospective study of 200 patients.

Guinault D, Del Bello A, Lavayssiere L, Nogier MB, Cointault O, Congy N, Esposito L, Hebral AL, Roques O, Kamar N, Faguer S.

BMC Anesthesiol. 2019 Jul 17;19(1):130. doi: 10.1186/s12871-019-0800-0.

16.

Correction to: Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study.

Olsøy IB, Henriksen S, Weissbach FH, Larsen M, Borgen K, Abravanel F, Kamar N, Paulssen EJ, Hirsch HH, Rinaldo CH.

Med Microbiol Immunol. 2019 Jun 22. doi: 10.1007/s00430-019-00626-5. [Epub ahead of print]

PMID:
31230105
17.

Screening, diagnosis and risks associated with Hepatitis E virus infection.

Lhomme S, Legrand-Abravanel F, Kamar N, Izopet J.

Expert Rev Anti Infect Ther. 2019 Jun;17(6):403-418. doi: 10.1080/14787210.2019.1613889. Epub 2019 May 13.

PMID:
31082277
18.

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.

Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, Kamar N, Merville P, Junge M, Thaiss F, Nashan B; Athena Study Group.

Kidney Int. 2019 Jul;96(1):231-244. doi: 10.1016/j.kint.2019.01.041. Epub 2019 Feb 27.

19.

Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients.

Allard M, Puszkiel A, Conti F, Chevillard L, Kamar N, Noé G, White-Koning M, Thomas-Schoemann A, Simon T, Vidal M, Calmus Y, Blanchet B.

Clin Ther. 2019 May;41(5):882-896.e3. doi: 10.1016/j.clinthera.2019.03.006. Epub 2019 Apr 17.

PMID:
31003735
20.

No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.

Del Bello A, Abravanel F, Alric L, Lavayssiere L, Lhomme S, Bellière J, Izopet J, Kamar N.

Transpl Infect Dis. 2019 Aug;21(4):e13093. doi: 10.1111/tid.13093. Epub 2019 Apr 30.

PMID:
30972874
21.

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

Mouna L, Rossignol E, Tateo M, Coilly A, Duclos-Vallée JC, Duvoux C, Durand F, Tran A, Radenne S, Canva-Delcambre V, Houssel-Debry P, Dumortier J, Conti F, de Ledinghen V, Leroy V, Kamar N, Di Martino V, Moreno C, Botta Fridlund D, d'Alteroche L, Lebray P, Perre P, Besch C, Silvain C, Habersetzer F, Debette-Gratien M, Abergel A, Diallo A, Samuel D, Roque-Afonso AM, Pageaux GP; ANRS CO23 CUPILT study group.

J Hepatol. 2019 Jun;70(6):1297-1300. doi: 10.1016/j.jhep.2019.02.019. Epub 2019 Apr 6. No abstract available.

PMID:
30967293
22.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
23.

Percutaneous transluminal angioplasty alone versus stent placement for the treatment of transplant renal artery stenosis.

Macchini M, Mokrane T, Darcourt J, Bellière J, Kamar N, Candelari R, Rousseau H, Meyrignac O.

Diagn Interv Imaging. 2019 Sep;100(9):493-502. doi: 10.1016/j.diii.2019.03.010. Epub 2019 Apr 2.

PMID:
30952527
24.

Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study.

Olsøy IB, Henriksen S, Weissbach FH, Larsen M, Borgen K, Abravanel F, Kamar N, Paulssen EJ, Hirsch HH, Rinaldo CH.

Med Microbiol Immunol. 2019 Mar 22. doi: 10.1007/s00430-019-00599-5. [Epub ahead of print] Erratum in: Med Microbiol Immunol. 2019 Jun 22;:.

PMID:
30903372
25.

Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.

Fontaine H, Alric L, Labreuche J, Legendre B, Louvet A, Antoine C, Legendre CM, Hazzan M, Kamar N, Dharancy S, Pol S, Duhamel A, Mathurin P.

J Hepatol. 2019 May;70(5):831-838. doi: 10.1016/j.jhep.2018.12.036. Epub 2019 Mar 14.

PMID:
30879789
26.

[Hepatitis E virus infection].

Marion O, Izopet J, Kamar N.

Rev Prat. 2018 Mar;68(3):286-290. French.

PMID:
30869287
27.

Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection?

Marion O, Lhomme S, Abravanel F, Izopet J, Kamar N.

Transpl Infect Dis. 2019 Jun;21(3):e13065. doi: 10.1111/tid.13065. Epub 2019 Mar 22. No abstract available.

PMID:
30860299
28.

Dynamic predictions of long-term kidney graft failure: an information tool promoting patient-centred care.

Fournier MC, Foucher Y, Blanche P, Legendre C, Girerd S, Ladrière M, Morelon E, Buron F, Rostaing L, Kamar N, Mourad G, Garrigue V, Couvrat-Desvergnes G, Giral M, Dantan E; DIVAT Consortium.

Nephrol Dial Transplant. 2019 Mar 11. pii: gfz027. doi: 10.1093/ndt/gfz027. [Epub ahead of print]

PMID:
30859193
29.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
30.

Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Jacquemont L, Hourmant M, Del Bello A, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Maillard N, Dubourg L, Lemoine S, Garrouste C, Pottel H, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2019 Apr;95(4):896-904. doi: 10.1016/j.kint.2018.11.029. Epub 2019 Feb 26.

PMID:
30819555
31.

No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant Patients.

Kamar N, Pan Q.

Hepatology. 2019 Apr;69(4):1846-1847. doi: 10.1002/hep.30546. Epub 2019 Mar 18. No abstract available.

PMID:
30723920
32.

Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection.

Marion O, Abravanel F, Izopet J, Kamar N.

Transpl Infect Dis. 2019 Apr;21(2):e13050. doi: 10.1111/tid.13050. Epub 2019 Feb 4. No abstract available.

PMID:
30663838
33.

Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients.

Marion O, Capelli N, Lhomme S, Dubois M, Pucelle M, Abravanel F, Kamar N, Izopet J.

J Infect. 2019 Mar;78(3):232-240. doi: 10.1016/j.jinf.2019.01.004. Epub 2019 Jan 17.

PMID:
30659856
34.

The Effectiveness of Topical Cerium Nitrate-Silver Sulfadiazine Application on Overall Outcome in Patients with Calciphylaxis.

Darres A, Delaval R, Fournier A, Tournier E, Cointault O, Moussion F, Chauveau D, Seigneuric B, Lumbroso C, Kamar N, Ribes D, Leou S, Huart A, Testevuide P, Faguer S.

Dermatology. 2019;235(2):120-129. doi: 10.1159/000493975. Epub 2019 Jan 3.

PMID:
30605905
35.

Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant.

Hage V, Ferrandiz I, Béllière J, Esposito L, Hebral AL, Cointault O, Del Bello A, Kamar N.

Exp Clin Transplant. 2019 Jun;17(3):313-319. doi: 10.6002/ect.2018.0043. Epub 2018 Dec 31.

36.

Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.

Marion O, Lhomme S, Del Bello A, Abravanel F, Esposito L, Hébral AL, Lavayssière L, Cointault O, Ribes D, Izopet J, Kamar N.

J Hepatol. 2019 Jan;70(1):206-209. doi: 10.1016/j.jhep.2018.09.011. Epub 2018 Oct 24. No abstract available.

PMID:
30563687
37.

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.

Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.

Adv Ther. 2019 Feb;36(2):462-477. doi: 10.1007/s12325-018-0855-1. Epub 2018 Dec 14.

PMID:
30552587
38.

Robot-assisted laparoscopic partial nephrectomy with renal artery clamping using an endovascular balloon catheter for an allograft kidney tumor: A new perspective to manage renal vascular control?

Laclergerie F, Delchier MC, Covin B, Sallusto F, Soulie M, Gamé X, Beauval JB, Kamar N, Roumiguié M, Doumerc N.

Am J Transplant. 2019 Apr;19(4):1239-1240. doi: 10.1111/ajt.15151. Epub 2018 Nov 10. No abstract available.

PMID:
30372583
39.

Do natural antibodies have a detrimental effect after kidney transplantation?

Del Bello A, Kamar N.

Ann Transl Med. 2018 Aug;6(16):316. doi: 10.21037/atm.2018.07.10. No abstract available.

40.

Performance of a commercial assay for detecting and quantifying HEV RNA in faeces.

Abravanel F, Lacipière A, Lhomme S, Dubois M, Minier L, Peron JM, Alric L, Kamar N, Izopet J.

J Clin Virol. 2018 Dec;109:1-5. doi: 10.1016/j.jcv.2018.10.003. Epub 2018 Oct 10.

PMID:
30336371
41.

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.

Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Gordon CE, Earley A, Di M, Martin P.

Kidney Int. 2018 Oct;94(4):663-673. doi: 10.1016/j.kint.2018.06.011.

42.

The age-calibrated measured glomerular filtration rate improves living kidney donation selection process.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Del Bello A, Girerd S, Kessler M, Flamant M, Vidal-Petiot E, Peraldi MN, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Caillard S, Gatault P, Büchler M, Maillard N, Dubourg L, Roquet O, Garrouste C, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2018 Sep;94(3):616-624. doi: 10.1016/j.kint.2018.05.016.

43.

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study.

Garaix F, Stern M, Lamy FX, Dubel L, Kamar N.

Ann Transplant. 2018 Aug 10;23:561-571. doi: 10.12659/AOT.908522.

44.

Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study.

Couvrat-Desvergnes G, Foucher Y, Le Borgne F, Dion A, Mourad G, Garrigue V, Legendre C, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Giral M, Dantan E.

Nephrol Dial Transplant. 2019 Apr 1;34(4):703-711. doi: 10.1093/ndt/gfy221.

PMID:
30060106
45.

Actinomycosis: An infrequent disease in renal transplant recipients?

Rousseau C, Piroth L, Pernin V, Cassuto E, Etienne I, Jeribi A, Kamar N, Pouteil-Noble C, Mousson C.

Transpl Infect Dis. 2018 Dec;20(6):e12970. doi: 10.1111/tid.12970. Epub 2018 Aug 11.

PMID:
30055044
46.

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.

Sérée O, Altieri M, Guillaume E, De Mil R, Lobbedez T, Robinson P, Segol P, Salamé E, Abergel A, Boillot O, Conti F, Chazouillères O, Debette-Gratien M, Debray D, Hery G, Dharancy S, Durand F, Duvoux C, Francoz C, Gugenheim J, Hardwigsen J, Houssel-Debry P, Jacquemin E, Kamar N, Latournerie M, Lebray P, Leroy V, Mazzola A, Neau-Cransac M, Pageaux GP, Radenne S, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Launoy G, Dumortier J.

Liver Transpl. 2018 Oct;24(10):1425-1436. doi: 10.1002/lt.25310.

47.

Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.

Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, Del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra A, Hofbauer GFL, Kamar N, Pouteil-Noble C, Kanitakis J, Roux A, Decullier E, Euvrard S; TUMORAPA Study Group.

J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17.

PMID:
30016177
48.

Acute hepatitis E in French patients and neurological manifestations.

Abravanel F, Pique J, Couturier E, Nicot F, Dimeglio C, Lhomme S, Chiabrando J, Saune K, Péron JM, Kamar N, Evrard S, de Valk H, Cintas P, Izopet J; HEV study group.

J Infect. 2018 Sep;77(3):220-226. doi: 10.1016/j.jinf.2018.06.007. Epub 2018 Jul 10.

PMID:
29966614
49.

Diversity of hepatitis E virus genotype 3.

Nicot F, Jeanne N, Roulet A, Lefebvre C, Carcenac R, Manno M, Dubois M, Kamar N, Lhomme S, Abravanel F, Izopet J.

Rev Med Virol. 2018 Sep;28(5):e1987. doi: 10.1002/rmv.1987. Epub 2018 Jun 25.

PMID:
29939461
50.

Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients.

Marion O, Abravanel F, Del Bello A, Esposito L, Lhomme S, Puissant-Lubrano B, Alric L, Faguer S, Izopet J, Kamar N.

Liver Int. 2018 Dec;38(12):2178-2189. doi: 10.1111/liv.13894. Epub 2018 Jun 14.

PMID:
29845733

Supplemental Content

Support Center